Potential Risks During Anaesthesia The main concern with GLP-1 receptor agonists during surgery relates to their effect on gastric emptying
Managing that timeline honestly, up front, is one of the most important skills a clinician can bring to this conversation
(e1239) Urva S, Coskun T, Loh MT et al (2022) LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
The company partners with established compounding pharmacies including Belmar Pharma Solutions and Beluga Health
10.3390/antiox12101867 105 TurkB
The FDA prescribing information for these agents lists common adverse effects including nausea, vomiting, diarrhea, constipation, and abdominal pain, but does not include blood clots among recognized risks